S Claiborne Johnston Selected Research

Transient Ischemic Attack

3/2022	Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy: A Post Hoc Analysis of a Randomized Clinical Trial.
1/2022	Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic Attack.
1/2022	Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
1/2022	Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack.
1/2022	Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack.
1/2022	Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial.
12/2021	Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA.
12/2021	Antiplatelet Use and Ischemic Stroke Risk in Minor Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the POINT Trial.
11/2021	Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
1/2021	Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Claiborne Johnston Research Topics

Disease

119	Stroke (Strokes) 11/2022 - 04/2003
74	Ischemic Stroke 11/2022 - 10/2003
58	Transient Ischemic Attack 03/2022 - 02/2004
47	Hemorrhage 01/2022 - 03/2005
15	Myocardial Infarction 01/2021 - 05/2004
10	Pathologic Constriction (Stenosis) 12/2020 - 04/2008
8	Cerebral Hemorrhage 11/2014 - 10/2003
7	Hypertension (High Blood Pressure) 01/2022 - 05/2004
7	Atrial Fibrillation 01/2021 - 02/2008
6	Infarction (Infarctions) 03/2022 - 06/2009
6	Peripheral Arterial Disease 10/2021 - 09/2005
5	Aneurysm (Aneurysms) 10/2021 - 09/2003
5	Intracranial Aneurysm (Cerebral Aneurysm) 10/2021 - 09/2003
5	Brain Ischemia (Cerebral Ischemia) 10/2019 - 10/2003
5	Sickle Cell Anemia (Hemoglobin S Disease) 01/2011 - 07/2004
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 10/2007
4	Atherosclerosis 12/2020 - 06/2010
4	Vascular Diseases (Vascular Disease) 01/2018 - 09/2004
4	Infections 05/2013 - 12/2005
3	Diabetes Mellitus 01/2022 - 10/2009
3	Thrombosis (Thrombus) 01/2021 - 09/2005
3	COVID-19 01/2021 - 10/2020
3	Hemorrhagic Stroke 09/2017 - 07/2012
3	Embolic Stroke 01/2017 - 07/2007
3	Inflammation (Inflammations) 05/2013 - 06/2010
3	Patent Foramen Ovale 01/2011 - 02/2006
3	Hyperhomocysteinemia 01/2011 - 02/2006
3	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2011 - 02/2006
3	Blood Vessel Dissection 01/2011 - 02/2006
3	Acute Coronary Syndrome 06/2009 - 05/2007
3	Arteriovenous Malformations (Arteriovenous Malformation) 10/2007 - 01/2006
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 10/2022 - 06/2009
2	Hyperglycemia 01/2022 - 11/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2006
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2021 - 01/2015
2	Ischemia 01/2020 - 06/2009
2	Pneumonia (Pneumonitis) 03/2017 - 09/2006
2	Dementia (Dementias) 01/2017 - 01/2005
2	Chlamydophila Infections 05/2013 - 06/2010
2	Dyslipidemias (Dyslipidemia) 11/2012 - 07/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2010 - 06/2010
2	Hypercholesterolemia 06/2010 - 10/2008
2	Obesity 06/2010 - 08/2006
2	Alzheimer Disease (Alzheimer's Disease) 10/2009 - 02/2004
1	Headache (Headaches) 10/2021
1	Ruptured Aneurysm 10/2021
1	Vascular Remodeling 10/2021
1	Traumatic Intracranial Hemorrhage 01/2021
1	Venous Thromboembolism 01/2021

Drug/Important Bio-Agent (IBA)

66	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022 - 01/2004
50	Clopidogrel (Plavix)FDA Link 11/2022 - 09/2005
27	TicagrelorIBA 01/2022 - 12/2015
11	Cytochrome P-450 CYP2C19IBA 11/2022 - 07/2016
10	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 10/2003
9	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 02/2006
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 10/2008
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2020
5	Warfarin (Coumadin)FDA LinkGeneric 10/2012 - 04/2008
5	CholesterolIBA 07/2011 - 05/2004
4	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 09/2005
4	Pharmaceutical PreparationsIBA 10/2021 - 09/2004
4	Hormones (Hormone)IBA 01/2011 - 02/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2003
3	LipidsIBA 10/2021 - 07/2006
3	AnticoagulantsIBA 01/2021 - 07/2007
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2020 - 06/2010
2	PolymersIBA 10/2021 - 05/2014
2	PlatinumIBA 10/2021 - 05/2014
2	MetalsIBA 10/2021 - 05/2014
2	Indicators and Reagents (Reagents)IBA 01/2021 - 12/2020
2	Natalizumab (Tysabri)FDA Link 01/2020 - 03/2017
2	oxidized low density lipoproteinIBA 01/2018 - 07/2006
2	IntegrinsIBA 03/2017 - 09/2014
2	InterleukinsIBA 05/2013 - 06/2010
2	RNA (Ribonucleic Acid)IBA 05/2013 - 12/2010
2	Dabigatran FDA Link 10/2012 - 03/2012
2	Interleukin-6 (Interleukin 6)IBA 06/2010 - 12/2005
2	HomocysteineIBA 10/2009 - 09/2007
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2009 - 02/2004
2	Dipyridamole (Persantine)FDA LinkGeneric 10/2009 - 04/2008
2	Ticlopidine (Ticlid)FDA LinkGeneric 02/2008 - 01/2004
2	ApolipoproteinsIBA 10/2007 - 05/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2007 - 01/2006
1	indobufenIBA 10/2022
1	Streptokinase FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 10/2021
1	Cilostazol (Pletal)FDA LinkGeneric 10/2021

Therapy/Procedure

49	Therapeutics 11/2022 - 09/2003
8	Secondary Prevention 01/2022 - 02/2005
6	Aftercare (After-Treatment) 10/2021 - 09/2003
4	Stents 09/2015 - 06/2009
3	Thrombectomy 01/2020 - 07/2011
3	Carotid Endarterectomy 01/2015 - 02/2004
3	Contraindications 10/2012 - 07/2010
2	Retreatment 05/2014 - 01/2008
2	Thrombolytic Therapy 05/2012 - 07/2005
2	Length of Stay 04/2010 - 09/2006
1	Duration of Therapy 01/2021